Back

Epidemiological characteristics and vaccination impact scenario modelling of concurrent Clade I mpox outbreaks in the Democratic Republic of the Congo and Burundi

McCabe, R.; Knock, E. S.; Halliday, A.; Cox, V. M.; Olivera Mesa, D.; Chopra, K.; Ajong, B.; Bizimana, J.-C.; Kalonji, T.; Kamatari, O.; Leng, T.; Maddren, R.; Mavoko, H. M.; Mbala, P.; Morel, G.; Nkengurutse, L.; Nsavyimana, O.; Nyandwi, J.; Parchani, K.; Pham, A.; Rawson, T.; Shaw, A.; Whittaker, C.; Ghani, A. C.; Ferguson, N. M.; Niyukuri, D.; Whittles, L. K.

2026-02-27 public and global health
10.64898/2026.02.24.26346883 medRxiv
Show abstract

In 2024, mpox cases surged in the Democratic Republic of the Congo (DRC) with cross-border spread to Burundi. We developed a transmission-dynamic model calibrated against surveillance data to understand drivers in enzootic (Clade Ia) and non-enzootic (Clade Ib) areas, and the potential impact of vaccination. In non-enzootic areas we estimated that 58-84% of transmission occurred within sexual networks. MVA-BN vaccination of sex workers could have averted 91% (95% CrI 81%-98%) of infections in Sud Kivu (DRC) but only 35% (95% CrI 26%-47%) in Bujumbura (Burundi), due to later outbreak detection. In historically enzootic Equateur (DRC), ongoing zoonotic spillover best explained sustained incidence. There, pledged Lc18m8 vaccines could have averted 42% (95% CrI 40%-46%) of infections; prioritising children improved impact. Across all settings, doubling vaccine coverage by using a single dose of MVA-BN outperformed two-dose strategies. Timely detection and tailored vaccination strategies are critical to reducing mpox burden.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 4%
22.0%
2
eLife
5422 papers in training set
Top 7%
9.8%
3
Emerging Infectious Diseases
103 papers in training set
Top 0.2%
6.6%
4
Nature Medicine
117 papers in training set
Top 0.5%
4.7%
5
PLOS Neglected Tropical Diseases
378 papers in training set
Top 2%
3.5%
6
The Lancet Infectious Diseases
71 papers in training set
Top 0.9%
3.0%
7
PLOS Medicine
98 papers in training set
Top 1%
3.0%
50% of probability mass above
8
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.7%
9
BMC Medicine
163 papers in training set
Top 2%
2.5%
10
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 2%
2.5%
11
Journal of Travel Medicine
18 papers in training set
Top 0.1%
2.3%
12
The Lancet Global Health
24 papers in training set
Top 0.5%
2.0%
13
The Lancet Regional Health - Western Pacific
15 papers in training set
Top 0.1%
1.8%
14
PLOS ONE
4510 papers in training set
Top 52%
1.7%
15
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.7%
16
Science Advances
1098 papers in training set
Top 18%
1.7%
17
Epidemics
104 papers in training set
Top 1%
1.7%
18
PLOS Global Public Health
293 papers in training set
Top 4%
1.7%
19
Transactions of The Royal Society of Tropical Medicine and Hygiene
16 papers in training set
Top 0.2%
1.7%
20
Vaccine
189 papers in training set
Top 1%
1.7%
21
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 34%
1.6%
22
PLOS Computational Biology
1633 papers in training set
Top 18%
1.4%
23
Infectious Diseases of Poverty
10 papers in training set
Top 0.2%
1.2%
24
Scientific Reports
3102 papers in training set
Top 70%
0.9%
25
The Lancet Microbe
43 papers in training set
Top 1%
0.9%
26
Nature Microbiology
133 papers in training set
Top 4%
0.9%
27
International Journal of Infectious Diseases
126 papers in training set
Top 3%
0.8%
28
Communications Biology
886 papers in training set
Top 22%
0.8%
29
Eurosurveillance
80 papers in training set
Top 2%
0.7%
30
Malaria Journal
48 papers in training set
Top 2%
0.7%